Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials (Q36330921)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

0 references

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Hertzel C. Gerstein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

2

object named as

Hisatomi Arima

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

object named as

Peter Reaven

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

9

object named as

Ruth L Coleman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Mark Woodward

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rodney A Hayward

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Timothy Craven

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Collaborators on Trials of Lowering Glucose (CONTROL) group

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

29 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

431-437

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Changes in diabetes-related complications in the United States, 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Need for better diabetes treatment for improved renal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(17)30104-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365411%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36330921&oldid=1833576854"